DEF: FiEE, Inc. Sets 2025 Annual Meeting Agenda

Sentiment:

Proxy Statement


FiEE, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on October 27, 2025, seeking approval for director elections, auditor ratification, common stock issuance, and a new equity incentive plan.

Capital raiseStockholder approval is sought for the issuance of shares of common stock upon the conversion of the Seller Convertible Note (principal amount of $300,000, conversion price of $0.25 per share) and the exercise of the Seller Warrant (404,002 shares, exercise price of $0.01 per share).These issuances are required to comply with Nasdaq Listing Rules 5635(c) and 5635(d) because the number of shares exceeds 20% of outstanding common stock and the conversion/exercise price is less than the Nasdaq Minimum Price.The proposed FiEE, Inc. 2025 Equity Incentive Plan makes 1,394,230 shares of common stock available for issuance, which could be used for future equity compensation, effectively a form of capital raise through stock-based incentives.On May 9, 2025, Cao Yu (CFO and Director) purchased 1,585,366 shares of Common Stock for $2,600,000.On May 9, 2025, Hu Bin (Director) purchased 853,659 shares of Common Stock for $1,400,000.
Worse than expectedThe company's former independent auditor, Beckles & Co., included a 'going concern' qualification in its report for the fiscal year ended December 31, 2024, due to significant operating losses, indicating substantial doubt about the company's ability to continue operations.Total Shareholder Return (TSR) experienced a 91% decrease from 2023 to 2024, as stated in the filing's pay versus performance analysis, indicating poor shareholder value creation.Compensation actually paid to the Principal Executive Officer (PEO) increased by 27% from 2023 to 2024, despite the significant decline in TSR, suggesting a disconnect between executive pay and company performance.The equity award burn rate for 2024 was 29.3%, a substantial increase from prior years, which implies significant dilution for existing shareholders.

Summary

  • The 2025 Annual Meeting of Stockholders will be held virtually on October 27, 2025, at 9:00 a.m. Eastern Time, with a record date of September 11, 2025.
  • Stockholders will vote on the election of four director nominees: Hu Bin, Cao Yu, Chan Oi Fat, and David Natan.
  • The appointment of UHY LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, is subject to ratification, following the dismissal of Beckles & Co. on July 11, 2025.
  • Approval is sought for the issuance of common stock upon the conversion of the Seller Convertible Note and the exercise of the Seller Warrant, to comply with Nasdaq Listing Rules 5635(c) and 5635(d).
  • The FiEE, Inc. 2025 Equity Incentive Plan, which reserves 1,394,230 shares of common stock, requires stockholder approval.
  • A non-binding advisory vote on the compensation of the company's named executive officers (say-on-pay) will also take place.
  • As of the record date, there were 6,295,961 outstanding shares of Common Stock (82.2% voting power) and 2,305,357 shares of Series A Convertible Preferred Stock, convertible into 1,367,538 shares of Common Stock (17.8% voting power).
  • The Board of Directors recommends a vote 'FOR' all proposals.

Sentiment

Score: 3

Explanation: While the company has achieved a Nasdaq relisting and is implementing new governance measures, the 'going concern' warning from its former auditor, coupled with significant operating losses, a high equity burn rate, and a substantial negative Total Shareholder Return, indicates severe underlying financial challenges and high investment risk. The proposed stock issuances also suggest significant dilution.

Positives

  • The company was relisted on the Nasdaq Capital Market on June 2, 2025, satisfying a key milestone.
  • The proposed 2025 Equity Incentive Plan incorporates several good corporate governance provisions, including a clawback policy, no repricing without stockholder approval, minimum one-year vesting, and no liberal share recycling.
  • Net Loss decreased significantly from $(17,633,924) in 2023 to $(4,224,278) in 2024, an approximately $13 million reduction.
  • The Board of Directors has established three standing committees (Audit, Nominating and Corporate Governance, Compensation) with independent members, enhancing oversight.

Negatives

  • The audit report for the fiscal year ended December 31, 2024, from former auditor Beckles & Co., included a 'going concern' paragraph due to significant operating losses.
  • Several directors and officers, including David Natan and David Lazar, were late in filing Section 16(a) reports (Form 4 and Form 3) due to administrative errors.
  • The company's equity award burn rate for 2024 was 29.3%, significantly higher than 1.8% in 2022 and 2.2% in 2023, indicating substantial dilution.
  • Compensation actually paid to the Principal Executive Officer (PEO) increased by 27% from 2023 to 2024, while the Total Shareholder Return (TSR) decreased by 91% over the same period, indicating a misalignment of pay and performance.

Risks

  • The company's significant operating losses raise substantial doubt about its ability to continue as a going concern, as noted by its former independent auditor.
  • Failure to obtain stockholder approval for the issuance of common stock related to the Seller Convertible Note and Seller Warrant could result in non-compliance with Nasdaq Listing Rules 5635(c) and 5635(d).
  • If the 2025 Equity Incentive Plan is not approved, the company may be at a significant disadvantage in attracting and retaining key talent, potentially leading to increased cash compensation and a misalignment with stockholder interests.
  • The issuance of shares under the Seller Convertible Note, Seller Warrant, and the 2025 Equity Incentive Plan poses a risk of dilution for existing stockholders.
  • Past administrative errors leading to late Section 16(a) filings by directors and officers indicate potential internal control weaknesses.

Future Outlook

The company anticipates that the 1,394,230 shares reserved under the proposed 2025 Equity Incentive Plan will be sufficient for attracting, motivating, and retaining employees, directors, and consultants for approximately 4 years. The company has successfully relisted on the Nasdaq Capital Market on June 2, 2025, fulfilling a key objective related to a services agreement with David Lazar, which aimed for a Nasdaq listing by December 31, 2025.

Management Comments

  • "We believe that equity awards are critical incentives to attracting, retaining and motivating our directors, officers and employees and are an important way of ensuring the interests of our talent are aligned with Company goals and stockholder interests."
  • "We firmly believe that employees with a stake in the future success of our business are highly motivated to achieve long-term growth and are well-aligned with the interests of our other equity-holders to increase stockholder value."
  • "Our Compensation Committee takes a thoughtful approach to managing our dilution and annual burn rate usage levels, taking into account business needs, competitive market practices, and our broader human capital management strategy."
  • "Our executive compensation programs are designed to attract, motivate, and retain our named executive officers, who are critical to our success, and to reward our named executive officers for the achievement of short-term and long-term strategic and operational goals and the achievement of increased total stockholder return."

Industry Context

The company operates in an intensely competitive industry for talent, necessitating the use of equity compensation to attract, retain, and motivate key personnel. The adoption of the 2025 Equity Incentive Plan is positioned as a critical tool to remain competitive and reduce reliance on cash compensation, aligning with common practices in industries where talent acquisition and retention are paramount. The company's recent relisting on the Nasdaq Capital Market indicates its commitment to maintaining a public market presence, which is crucial for access to capital and investor visibility in its sector.

Comparison to Industry Standards

  • The company states its compensation packages are designed to be competitive within its industry, aiming to attract and retain qualified individuals.
  • The 2025 Equity Incentive Plan is intended to enable the company to remain competitive with industry peers in offering equity awards.
  • The 2024 equity award burn rate of 29.3% is significantly higher than the company's previous years (1.8% in 2022, 2.2% in 2023), and could be considered high compared to industry averages, especially for mature companies, though it is attributed to one-time grants.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive Officer and PresidentJeremy Hitchcock (CEO until Aug 2024)Li Wai ChungFebruary 2025 (CEO), March 2025 (President)Appointment
Chief Financial Officer and DirectorDavid Lazar (CFO until Feb 2025)Cao YuApril 2025Appointment
DirectorHu BinApril 2025Appointment
DirectorChan Oi FatApril 2025Appointment
DirectorDavid Natan (resigned Feb 2025)David Natan (re-appointed)April 29, 2025Re-appointment
Chief Executive Officer, Chairman and DirectorJeremy HitchcockAugust 3, 2024 (CEO), June 30, 2025 (Director)Resignation (Jeremy Hitchcock), Resignation (David Lazar)
DirectorAndrew PapanicolauFebruary 19, 2025Resignation
DirectorPatrick RivardFebruary 19, 2025Resignation
DirectorAvraham Ben-TzviFebruary 19, 2025Resignation
DirectorMatthew McMurdoFebruary 19, 2025Resignation

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe Board of Directors reviews and determines the independence of its members in accordance with Nasdaq Listing Rules and SEC regulations. Hu Bin, David Natan, and Chan Oi Fat have been determined to be independent.OngoingEnhances board independence and oversight, aligning with best practices for publicly traded companies.
Board MeetingsThe Board of Directors held 35 meetings during the fiscal year ended December 31, 2024, with most directors attending at least 75% of meetings.Fiscal Year 2024Indicates active board engagement and oversight.
Committee StructureThe Board has established three standing committees: Audit, Nominating and Corporate Governance, and Compensation. All committee members meet Nasdaq and SEC independence criteria.OngoingProvides specialized oversight for critical areas like financial reporting, director nominations, and executive compensation.
Audit CommitteeComposed of Hu Bin, David Natan (Chair), and Chan Oi Fat. David Natan qualifies as a financial expert. The committee held 8 meetings in 2024.OngoingEnsures robust oversight of financial statements, internal controls, and auditor performance.
Nominating and Corporate Governance CommitteeComposed of Hu Bin, David Natan, and Chan Oi Fat (Chair). The committee held no meetings in 2024.OngoingResponsible for director nominations and corporate governance guidelines, though lack of meetings in 2024 could be a concern.
Compensation CommitteeComposed of Hu Bin, David Natan, and Chan Oi Fat (Chair). The committee held no meetings in 2024.OngoingResponsible for executive compensation philosophy and plans, though lack of meetings in 2024 could be a concern.
Board Leadership StructureThe roles of Chairman of the Board (Hu Bin, independent director) and Chief Executive Officer (Li Wai Chung) are held by different individuals.OngoingSeparates leadership roles, allowing the CEO to focus on operations and the Chairman to lead board oversight, potentially enhancing independent governance.
Risk OversightThe Board is ultimately responsible for risk management oversight, primarily through its committees and management reporting.OngoingEstablishes a structured approach to identifying, assessing, and mitigating material risks.
Insider Trading PolicyAn insider trading policy was adopted on May 30, 2025, prohibiting short sales by directors, officers, and employees. The company does not currently have a policy regarding hedging activities.2025-05-30Strengthens ethical conduct and prevents certain speculative trading by insiders, though the absence of a hedging policy leaves a potential gap.
2025 Equity Incentive Plan ProvisionsThe proposed 2025 Equity Incentive Plan includes provisions such as no evergreen feature, no liberal share recycling, a minimum one-year vesting requirement (with limited exceptions), a clawback policy, no repricing without stockholder approval, no transferability (with exceptions), and no single-trigger vesting upon a change in control.Upon stockholder approval (October 27, 2025)Aligns the plan with strong corporate governance practices, protecting stockholder interests and promoting long-term value creation.

Related Party Transactions

  • On February 18, 2025, the company entered into an Amended and Restated Securities Purchase Agreement with former director David Lazar (Seller) and Purchasers (Cao Yu, Hu Bin, and Youxin Consulting Limited). Lazar sold 2,219,447 shares of Series A Convertible Preferred Stock, a warrant to purchase 2,800,000 shares of Common Stock, and certain receivables to the Purchasers for $500,000.
  • On May 9, 2025, the company entered into a Second Amended and Restated Investor Purchase Agreement with David Lazar and the Investor Purchasers, rescinding previous stock issuances and replacing them with a Convertible Note. The Investor Purchasers agreed to surrender Lazar Warrants and forgive Lazar Receivables.
  • On May 9, 2025, the company and David Lazar entered into an unsecured promissory note (Seller Convertible Note) for a principal amount of $300,000, convertible into 1,214,839 shares of Common Stock at $0.25 per share upon stockholder approval.
  • On May 9, 2025, the company entered into a services agreement with David Lazar to achieve Nasdaq listing milestones.
  • On July 2, 2025, the company issued a warrant (Seller Warrant) to David Lazar to purchase up to 404,002 shares of Common Stock, exercisable upon stockholder approval.
  • On May 9, 2025, the company sold 1,585,366 shares of Common Stock to Cao Yu (Chief Financial Officer and Director) for $2,600,000.
  • On May 9, 2025, the company sold 853,659 shares of Common Stock to Hu Bin (Director) for $1,400,000.
  • Cao Yu (Chief Financial Officer, Secretary, Treasurer, and Director) is the niece of Hu Bin (Director).

Stakeholder Impact

  • **Shareholders**: Face potential dilution from the issuance of shares related to the Seller Convertible Note and Seller Warrant, as well as the 2025 Equity Incentive Plan. The significant negative Total Shareholder Return (TSR) indicates poor past performance. They will vote on critical governance and financial proposals.
  • **Employees**: The proposed 2025 Equity Incentive Plan is designed to attract, retain, and motivate employees through equity awards, aligning their interests with company growth.
  • **Management**: Executive compensation is subject to a non-binding advisory vote. The new equity plan aims to incentivize and retain key management personnel. Past late Section 16(a) filings by some officers and directors highlight compliance issues.
  • **Creditors**: The 'going concern' qualification from the former auditor raises concerns about the company's financial stability and ability to meet its obligations, potentially impacting creditworthiness.
  • **Regulatory Bodies (Nasdaq, SEC)**: The company is seeking stockholder approval to comply with Nasdaq Listing Rules, demonstrating an effort to meet regulatory requirements and maintain its listing status. Past Section 16(a) filing delinquencies indicate areas for improved compliance.

Next Steps

  • Hold the 2025 Annual Meeting of Stockholders on October 27, 2025, to vote on the proposed agenda items.
  • Elect four director nominees to serve on the Board of Directors.
  • Ratify the appointment of UHY LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
  • Approve the issuance of common stock upon the conversion of the Seller Convertible Note and the exercise of the Seller Warrant.
  • Approve the FiEE, Inc. 2025 Equity Incentive Plan.
  • Conduct a non-binding advisory vote on executive compensation.
  • If the 2025 Equity Incentive Plan is not approved, the existing 2021 Plan will remain in effect for future equity awards.
  • The company will take actions to amend its certificate of incorporation to increase the Stated Value of Series A Convertible Preferred Stock from $1.40 to $2.75 in consideration for cancelling Lazar Warrants and forgiving Lazar Receivables.

Key Dates

DateDescription
2000-10-01Li Wai Chung started career at Deloitte China as an audit manager.
2000-11-01Li Wai Chung received a bachelor's degree in accounting and finance from the University of Hong Kong.
2002-02-01David Natan began serving as Executive Vice President of Reporting and Chief Financial Officer of Pharma Net Development Group, Inc.
2011-03-01Cao Yu began serving as treasury officer of financial department of Suzhou Industrial Park Xinfushida Plastic Profile Products Co., Ltd.
2013-11-01Li Wai Chung received a master's degree in business administration from the University of Hong Kong.
2014-06-01Chan Oi Fat began serving as an independent non-executive director of Shanghai Prime Machinery Company Limited.
2016-02-01Cao Yu began serving as a business manager of Yangfeng Art Exchange Co., Ltd.
2016-08-01Li Wai Chung began serving as the general manager of the investment department of Lens Technology Co. Ltd.
2017-10-01Li Wai Chung began serving as a partner of Shanghai Yongxuan Venture Capital Management Co., Ltd.
2018-03-01Chan Oi Fat became Vice President Finance of SML Group Corporation.
2018-11-01Cao Yu began serving as the treasury director of Taifeng Cultural Communication Co., Ltd.
2020-06-01Li Wai Chung began serving as the executive director and Chief Financial Officer of Tyfon Culture Holdings Limited.
2020-06-01Chan Oi Fat began serving as an independent non-executive director of China Saftower International Holding Group Limited.
2020-11-01Chan Oi Fat became Company Secretary of Raily Aesthetic Medicine International Holdings Limited.
2022-02-01David Natan became a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc.
2022-08-16Mehul Patel served as the principal executive officer.
2022-08-16Dustin Tacker served as the principal financial officer.
2023-04-07Jeremy Hitchcock served as the principal executive officer.
2023-08-09Jeremy Hitchcock served as the principal financial officer.
2023-11-01David Natan served as a director of the Company.
2024-01-23Company entered into a Securities Purchase Agreement with David Lazar.
2024-02-20Company entered into a three-year employment agreement with David Lazar to act as CEO/CFO.
2024-02-01Company held a special meeting of stockholders.
2024-05-01Beckles & Co. became the independent registered public accounting firm.
2024-05-01Chan Oi Fat began serving as an independent non-executive director of UBoT Holding Limited.
2024-08-03Jeremy Hitchcock resigned from the Board and as CEO.
2024-12-01Hu Bin began serving as a director of DC International Service Trade GmbH.
2024-12-31Fiscal year ended.
2025-02-01Li Wai Chung began serving as Chief Executive Officer.
2025-02-18Company entered into an Amended and Restated Securities Purchase Agreement with David Lazar and Purchasers.
2025-02-19Andrew Papanicolau, Patrick Rivard, Avraham Ben-Tzvi, and Matthew McMurdo resigned from the Board.
2025-02-26David Lazar ceased serving as principal executive officer and principal financial officer.
2025-03-01Li Wai Chung began serving as President.
2025-03-01Chan Oi Fat began serving as an independent non-executive director of Huajin International Holdings Limited.
2025-04-01Cao Yu began serving as Chief Financial Officer and Director.
2025-04-01Hu Bin began serving as Director.
2025-04-01Chan Oi Fat began serving as Director.
2025-04-10Seller transferred 31,258 additional shares of Preferred Stock to Purchasers.
2025-04-29David Natan was re-appointed as a director.
2025-04-29Company entered into Director Agreements with Chan Oi Fat and David Natan.
2025-05-05Nasdaq Submission filed with Nasdaq.
2025-05-09Company entered into a Second Amended and Restated Investor Purchase Agreement with Seller and Purchasers.
2025-05-09Company entered into a Securities Purchase Agreement with Cao Yu.
2025-05-09Company entered into a Securities Purchase Agreement with Hu Bin.
2025-05-09Company entered into a services agreement with David Lazar.
2025-05-09Company and David Lazar entered into an unsecured promissory note (Convertible Note).
2025-05-30Insider trading policy adopted.
2025-06-02Company was relisted on Nasdaq Capital Market.
2025-06-30David Lazar resigned.
2025-07-02Company issued a warrant to David Lazar to purchase up to 404,002 shares of Common Stock (Seller Warrant).
2025-07-08Company entered into Director Agreements with Cao Yu and Hu Bin.
2025-07-11Audit Committee approved the dismissal of Beckles & Co. and the selection of UHY LLP.
2025-07-16Form 8-K filed with the SEC regarding the change in independent registered public accounting firm.
2025-09-11Record date for determining stockholders entitled to notice of and to vote at the 2025 Annual Meeting.
2025-09-15Closing price of the Common Stock was $2.92.
2025-09-22Proxy Statement, form of proxy, and accompanying materials first delivered or sent to stockholders.
2025-10-272025 Annual Meeting of Stockholders to be held.
2025-12-31Outstanding principal balance of the Seller Convertible Note shall be paid in full on or prior to this date.
2025-12-31Target date for achieving a Nasdaq listing under the Services Agreement with David Lazar.
2026-05-25Deadline for stockholder proposals to be included in the company's proxy materials for the 2026 Annual Meeting (Rule 14a-8).
2026-06-29Deadline for stockholder proposals or director nominations for the 2026 Annual Meeting (Bylaws).

Recommendation

sell

The company faces severe financial distress, evidenced by the 'going concern' qualification from its former auditor due to significant operating losses. The substantial 91% decrease in Total Shareholder Return (TSR) from 2023 to 2024, coupled with a 27% increase in PEO compensation over the same period, indicates a significant misalignment between executive pay and shareholder value creation. The high equity award burn rate of 29.3% in 2024 and the proposed issuance of common stock at a price below the Nasdaq Minimum Price for the Seller Convertible Note and Seller Warrant suggest substantial future dilution for existing shareholders. While the Nasdaq relisting is a positive step, it does not fundamentally address the underlying financial viability issues. These factors collectively point to a high-risk investment with significant downside potential, making a 'sell' recommendation appropriate for seasoned investors.

Keywords

FiEE Inc., FIEE, Proxy Statement, Annual Meeting, Corporate Governance, Director Election, Auditor Ratification, Equity Incentive Plan, Stock Issuance, Convertible Note, Warrant, Nasdaq Listing, Executive Compensation, Related Party Transactions, Going Concern, Financial Reporting, UHY LLP, Beckles & Co.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.